Apg Asset Management Us Inc. Biomarin Pharmaceutical Inc Transaction History
Apg Asset Management Us Inc.
- $12.8 Billion
- Q1 2025
A detailed history of Apg Asset Management Us Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Apg Asset Management Us Inc. holds 3,934 shares of BMRN stock, worth $217,432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,934
Previous 3,934
-0.0%
Holding current value
$217,432
Previous $258,000
7.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$982 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$827 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$597 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...